-
公开(公告)号：US09029406B2
公开(公告)日：2015-05-12
申请号：US14004699
申请日：2012-03-12
申请人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Stelte-Ludwig , Joachim Schuhmacher , Mark Gnoth
发明人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Stelte-Ludwig , Joachim Schuhmacher , Mark Gnoth
IPC分类号： C07D207/333 , C07D413/12 , C07D403/12 , A61K31/4025 , A61K31/4245 , A61K38/07 , C07K5/02 , A61K45/06 , C07K5/103 , A61K38/00 , A61K47/48
CPC分类号： A61K38/07 , A61K38/00 , A61K45/06 , A61K47/6415 , C07K5/0205
摘要： The present application relates to new derivatives, substituted on the N terminus by a carboxyalkyl group, of monomethylauristatin E and monomethylauristatin F, to processes for preparing these derivatives, to the use of these derivatives for treating and/or preventing diseases, and to the use of these derivatives for producing medicaments for treating and/or preventing diseases, more particularly hyperproliferative and/or angiogenic disorders such as cancer disorders, for example. Such treatments may be applied as a monotherapy or else in combination with other medicaments or further therapeutic measures.
摘要翻译： 本申请涉及在N末端被羧基烷基取代的单甲基海洛定蛋白E和单甲基海洛定蛋白F的新衍生物，用于制备这些衍生物的方法，这些衍生物用于治疗和/或预防疾病的用途和用途 的这些衍生物用于制备用于治疗和/或预防疾病的药物，更具体地是过度增殖和/或血管生成障碍，例如癌症病症。 这样的治疗可以作为单一疗法应用，也可以与其它药物组合使用或其它治疗措施。
-
公开(公告)号：US08987209B2
公开(公告)日：2015-03-24
申请号：US13876777
申请日：2011-09-26
申请人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Stelte-Ludwig , Sven Golfier , Joachim Schuhmacher , Jean Mark Gnoth , Ursula Krenz
发明人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Stelte-Ludwig , Sven Golfier , Joachim Schuhmacher , Jean Mark Gnoth , Ursula Krenz
CPC分类号： C07K5/1021 , A61K38/00 , A61K38/07 , A61K38/08 , A61K45/06 , C07K1/1077 , C07K5/0205 , C07K7/02
摘要： The present application relates to new derivatives of monomethylauristatin F, substituted on the N terminus by a carboxyalkyl group, processes for preparing these derivatives, their use for the treatment and/or prevention of diseases and to produce medication for the treatment and/or prevention of diseases, particularly hyperproliferative and/or angiogenic disorders such as cancer disorders, for example. Such treatments can occur as monotherapies or in combination with other medication or further therapeutic measures.
摘要翻译： 本申请涉及通过羧基烷基在N末端被取代的单甲基海洛定蛋白F的新衍生物，用于制备这些衍生物的方法，其用于治疗和/或预防疾病以及产生用于治疗和/或预防 疾病，特别是过度增生和/或血管发生疾病，例如癌症。 这种治疗可以作为单一疗法发生，或与其他药物或其他治疗措施组合发生。
-
3.发明授权Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors 失效杂环氧基取代的苯基氨基嘧啶作为rho激酶抑制剂公开(公告)号：US07737153B2
公开(公告)日：2010-06-15
申请号：US10531889
申请日：2003-10-16
申请人： Achim Feurer , Samir Bennabi , Heike Heckroth , Hartmut Schirok , Joachim Mittendorf , Raimund Kast , Johannes-Peter Stasch , Jean Mark Gnoth , Klaus Münter , Dieter Lang , Santiago Figueroa Perez , Heimo Ehmke
发明人： Achim Feurer , Samir Bennabi , Heike Heckroth , Hartmut Schirok , Joachim Mittendorf , Raimund Kast , Johannes-Peter Stasch , Jean Mark Gnoth , Klaus Münter , Dieter Lang , Santiago Figueroa Perez , Heimo Ehmke
IPC分类号： A01N43/90 , A61K31/519 , A61K31/505 , C07D487/00 , C07D239/02 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00
CPC分类号： C07D401/14 , C07D403/12 , C07D471/04
摘要： The invention relates to heteroaryloxy-substituted phenylaminopyrimidines, to methods for the production thereof, and to the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases. The inventive compounds inhibit Rho-Kinase.
摘要翻译： 本发明涉及杂芳氧基取代的苯基氨基嘧啶，其制备方法及其用于制备用于治疗和/或预防疾病，特别是心血管疾病的药物。 本发明化合物抑制Rho-激酶。
-
公开(公告)号：US20140080763A1
公开(公告)日：2014-03-20
申请号：US14004699
申请日：2012-03-12
申请人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Stelte-Ludwig , Joachim Schuhmacher , Mark Gnoth
发明人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Stelte-Ludwig , Joachim Schuhmacher , Mark Gnoth
CPC分类号： A61K38/07 , A61K38/00 , A61K45/06 , A61K47/6415 , C07K5/0205
摘要： The present application relates to new derivatives, substituted on the N terminus by a carboxyalkyl group, of monomethylauristatin E and monomethylauristatin F, to processes for preparing these derivatives, to the use of these derivatives for treating and/or preventing diseases, and to the use of these derivatives for producing medicaments for treating and/or preventing diseases, more particularly hyperproliferative and/or angiogenic disorders such as cancer disorders, for example. Such treatments may be applied as a monotherapy or else in combination with other medicaments or further therapeutic measures.
摘要翻译： 本申请涉及在N末端被羧基烷基取代的单甲基海洛定蛋白E和单甲基海洛定蛋白F的新衍生物，用于制备这些衍生物的方法，这些衍生物用于治疗和/或预防疾病的用途和用途 的这些衍生物用于制备用于治疗和/或预防疾病的药物，更具体地是过度增殖和/或血管生成障碍，例如癌症病症。 这样的治疗可以作为单一疗法应用，也可以与其它药物组合使用或其它治疗措施。
-
公开(公告)号：US20130261064A1
公开(公告)日：2013-10-03
申请号：US13876777
申请日：2011-09-26
申请人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Srelte Ludwig , Sven Golfier , Joachim Schumacher , Joan Mark Gnoth , Ursula Krenz
发明人： Hans-Georg Lerchen , Sherif El Sheikh , Beatrix Srelte Ludwig , Sven Golfier , Joachim Schumacher , Joan Mark Gnoth , Ursula Krenz
CPC分类号： C07K5/1021 , A61K38/00 , A61K38/07 , A61K38/08 , A61K45/06 , C07K1/1077 , C07K5/0205 , C07K7/02
摘要： The present application relates to new derivatives of monomethylauristatin F, substituted on the N terminus by a carboxyalkyl group, processes for preparing these derivatives, their use for the treatment and/or prevention of diseases and to produce medication for the treatment and/or prevention of diseases, particularly hyperproliferative and/or angiogenic disorders such as cancer disorders, for example. Such treatments can occur as monotherapies or in combination with other medication or further therapeutic measures.
摘要翻译： 本申请涉及通过羧基烷基在N末端被取代的单甲基海洛定蛋白F的新衍生物，用于制备这些衍生物的方法，其用于治疗和/或预防疾病以及产生用于治疗和/或预防 疾病，特别是过度增生和/或血管发生疾病，例如癌症。 这种治疗可以作为单一疗法发生，或与其他药物或其他治疗措施组合发生。
-
-
-
-
搜索结果
5 条记录 (耗时 0.016 秒)